Creating the optimal pathway for your highly-potent small molecule drug candidate through each clinical phase is critical to your success. This webinar explains how to choose the right partner with the right expertise for your HPAPI development journey, from early phase to commercialization through innovation in manufacturing technology and flexible business models. Supported by a case study, we show how Lonza has developed an innovative production offering to accelerate development and provide a more flexible (HP)API supply for customers through the full product lifecycle.
You may also be interested in:
Latest content
Latest briefing from the Knowledge Center